Calcium Channel Blockers in Critical Care Medicine: Current Clinical Applications and Future Investigational Perspectives
Calcium channel blockers (CCBs) are frequently used in the emergency department and intensive care unit for a wide range of critical conditions, including atrial fibrillation, hypertensive emergencies, acute pulmonary edema with sympathetic crashing, pulmonary hypertension, and vasospastic syndromes. However, their toxicity can lead to significant hemodynamic compromise, underscoring the importance of understanding their pharmacologic effects and safety profile. This review summarizes the current applications of CCBs in critically ill patients, evaluates their safety in congestive heart failure, and highlights emerging therapeutic roles and recent advances in the management of CCB toxicity.
Authors
- Akram M Eraky (ORCID: https://orcid.org/0000-0003-4219-3659)
- Yasser Mokhtar
- Nichole Gadd
- Guy Grabau
- Adnan Khan
- Mark Jarosz
- Abhishek Premkumar
- Ashish Acharya
Institutions
- Kansas City University (US)
- SUNY Upstate Medical University (US)
- Freeman Health System (US)
Publication Details
- Journal
- Medical Sciences
- Published
- 2026-04-25
- DOI
- https://doi.org/10.3390/medsci14020213
- Primary Topic
- Poisoning and overdose treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00